Guideline-Based AI Segmentation

Refining Volumes – a Study on Cardiac Substructures’ Impact on Survival in Lung Cancer Patients Treated with Radiation Therapy

Cardiac diseases and cancers are leading causes of death [1]. Many cancer patients have preexistent cardiac impairment or have risk factors of developing it. On…

MVision AI receives TGA approval and market authorization for Australia

HELSINKI, Finland – May 1, 2024 An application for MVision AI Segmentation (Contour+) has been submitted and accepted by the Therapeutic Goods Administration (TGA) under…

Dharanipathy Rangaraj Appointed as CEO of MVision AI

Helsinki, Uusimaa – April 29, 2024 – MVision AI, a pioneering company in developing innovative AI solutions in the radiation oncology & imaging space, proudly…

MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON)

Finland, Helsinki, February 19, 2024 The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies…

World Cancer Day – Joining efforts for a better cancer care

World cancer day, celebrated on the 4th of February, was established more than 20 years ago. It represents an initiative of the Union for International…

MVision AI Announces Partnership with Medron Medical Systems (Canada)

HELSINKI, Finland – January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces…

Contour+ performance on Male Pelvis synthetic CTs

Results of MVision AI’s solutions scientific evaluation were presented at the previous ASTRO annual meeting. One of the posters included data from paired MRI and…

NCCC Evaluation of MVision AI contouring software

S Warren, N Richmond MVision AI software has been under evaluation at NCCC (Newcastle upon Tyne Hospitals NHS Foundation Trust) since 28 February 2022* in…

RT for Prostate Cancer: Faster and Better – Is it Possible?

Background Worldwide, more than 1 400 000 men were diagnosed with prostate cancer in 2020, and it is estimated that one third will need radiotherapy…

MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform

Helsinki – 19th of January, 2022 – MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education…